Cargando…
The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen
Background: Pro re nata (PRN) regimen using anti-vascular endothelial growth factor (VEGF) agent is popular for the treatment of diabetic macular edema (DME). We investigated the influence of waiting time (WT) and interval between the date of recurrence of edema and re-injection on treatment efficac...
Autores principales: | Takamura, Yoshihiro, Kida, Teruyo, Noma, Hidetaka, Inoue, Makoto, Yoshida, Shigeo, Nagaoka, Taiji, Noda, Kousuke, Yamada, Yutaka, Morioka, Masakazu, Gozawa, Makoto, Matsumura, Takehiro, Inatani, Masaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705544/ https://www.ncbi.nlm.nih.gov/pubmed/34945035 http://dx.doi.org/10.3390/jcm10245738 |
Ejemplares similares
-
Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema
por: Oshima, Hideyuki, et al.
Publicado: (2022) -
Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
por: Yamada, Yutaka, et al.
Publicado: (2022) -
Turnover of Microaneurysms After Intravitreal Injections of Faricimab for Diabetic Macular Edema
por: Takamura, Yoshihiro, et al.
Publicado: (2023) -
Direct Photocoagulation Guided by Merged Retinal Images for the Treatment of Focal Diabetic Macular Edema
por: Takamura, Yoshihiro, et al.
Publicado: (2018) -
Comparison of the intraocular pressure following an intravitreal triamcinolone acetonide injection for diabetic macula oedema in vitrectomised and non-vitrectomised eyes
por: Orii, Yusuke, et al.
Publicado: (2021)